



@article {2237,
	title = {Pectin-based injectable biomaterials for bone tissue engineering},
	journal = {BiomacromoleculesBiomacromolecules},
	volume = {12},
	year = {2011},
	note = {Cited By (since 1996): 6Export Date: 21 November 2012Source: ScopusCODEN: BOMAFdoi: 10.1021/bm101110xPubMed ID: 21302960Language of Original Document: EnglishCorrespondence Address: Munarin, F.; Biomatlab, Bioengineering Department, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133, Milan, Italy; email: fabiola.munarin@mail.polimi.itChemicals/CAS: arginylglycylaspartic acid, 99896-85-2; osteocalcin, 136461-80-8; pectin, 9000-69-5; Biocompatible Materials; Oligopeptides; Pectins; arginyl-glycyl-aspartic acid, 99896-85-2; pectin, 9000-69-5References: Brown, M.J., Lester, J.N., (1980) Appl. Environ. Microbiol., 40, pp. 179-185;Knox, J.P., (2008) Curr. Opin. Plant Biol., 1, pp. 308-313; 
Jarvis, M.C., (1984) Plant, Cell Environ, 7, pp. 153-164; 
Thom, D., Grant, G.T., Morris, E.R., Rees, D.A., (1982) Carbohydr. Res., 100, pp. 29-42; 
Fang, Y., Al-Assaf, S., Phillips, G.O., Nishinari, K., Funami, T., Williams, P.A., (2008) Carbohydr. Polym., 72, pp. 334-341; 
Rowley, J.A., Madlambayan, G., Mooney, D.J., (1999) Biomaterials, 20, pp. 45-53; 
Price, L.S., (1997) Bioessays, 19, pp. 941-943; 
Dee, K.C., Andersen, T.T., Bizios, R., (1999) Biomaterials, 20, pp. 221-227; 
Pierschbacher, M.D., Ruoslahti, E., (1984) Nature, 309, pp. 30-33; 
Ruoslahti, E., Pierschbacher, M., (1987) Science, 238, pp. 491-497; 
Hynes, R.O., (1992) Cell, 69, pp. 11-25; 
Yamada, K.M., (1997) Matrix Biol., 16, pp. 137-141; 
Evangelista, M.B., Hsiong, S.X., Fernandes, R., Sampaio, P., Kong, H., Barrias, C.C., Salema, R., Granja, P.L., (2007) Biomaterials, 28, pp. 3644-3655; 
Grellier, M., Granja, P.L., Fricain, J., Bidarra, S.J., Renard, M., Bareille, R., Bourget, C., Barbosa, M.A., (2009) Biomaterials, 30, pp. 3271-3278; 
Liu, L., Fishman, M.L., Kost, J., Hicks, K.B., (2003) Biomaterials, 24, pp. 3333-3343; 
Rao, K.P., Prabhashankar, B., Kumar, A., Khan, A., Biradar, S.S., Srishail, S.P., Satyanath, B., (2003) Yale J. Biol. Med., 76, pp. 149-154; 
Jackson, C.L., Dreaden, T.M., Theobald, L.K., Tran, N.M., Beal, T.L., Eid, M., Gao, M.Y., Mohnen, D., (2007) Glycobiology, 17, pp. 805-819; 
Glinsky, V.V., Raz, A., (2009) Carbohydr. Res., 344, pp. 1788-1791; 
Vayssade, M., Sengkhamparn, N., Verhoef, R., Delaigue, C., Goundiam, O., Vigneron, P., Voragen, A.G., Nagel, M.D., (2010) Phytother. Res., 24, pp. 982-989; 
Katav, T., Liu, L., Traitel, T., Goldbart, R., Wolfson, M., Kost, J., (2008) J. Controlled Release, 130, pp. 183-191; 
Opanasopit, P., Apirakaramwong, A., Ngawhirunpat, T., Rojanarata, T., Ruktanonchai, U., (2008) AAPS PharmSciTech, 9, pp. 67-74; 
Morra, M., Cassinelli, C., Cascardo, G., Nagel, M., Della Volpe, C., Siboni, S., Maniglio, D., Ulvskov, P., (2004) Biomacromolecules, 5, pp. 2094-2104; 
Bussy, C., Verhoef, R., Haeger, A., Morra, M., Duval, J., Vigneron, P., Bensoussan, A., Nagel, M.D., (2008) J. Biomed. Mater. Res. A, 86, pp. 597-606; 
Kokkonen, H.E., Ilvesaro, J.M., Morra, M., Schols, H.A., Tuukkanen, J., (2007) Biomacromolecules, 8, pp. 509-515; 
Munarin, F., Giuliano, L., Bozzini, S., Tanzi, M.C., Petrini, P., (2010) Mater. Sci. Eng. C, 30, pp. 491-496; 
Karageorgiou, V., Kaplan, D., (2005) Biomaterials, 26, pp. 5474-5491; 
Volkmer, E., Drosse, I., Otto, S., Stangelmayer, A., Stengele, M., Kallukalam, B.C., Mutschler, W., Schieker, M., (2008) Tissue Eng., Part A, 14, pp. 1331-1340; 
Anselme, K., (2000) Biomaterials, 21, pp. 667-681; 
Hersel, U., Dahmen, C., Kessler, H., (2003) Biomaterials, 24, pp. 4385-4415; 
Stains, J.P., Civitelli, R., (2005) Birth Defects Res., Part C, 75, pp. 72-80; 
Ichibouji, T., Miyazaki, T., Ishida, E., Ashizuka, M., Sugino, A., Ohtsuki, C., Kuramoto, K., (2008) J. Ceram. Soc. Jpn., 116, pp. 74-78
},
	month = {2011///},
	pages = {568 - 577},
	abstract = {A variety of natural polymers and proteins are considered to be 3D cell culture structures able to mimic the extracellular matrix (ECM) to promote bone tissue regeneration. Pectin, a natural polysaccharide extracted from the plant cell walls and having a chemical structure similar to alginate, provides interesting properties as artificial ECM. In this work, for the first time, pectin, modified with an RGD-containing oligopeptide or not, is used as an ECM alternative to immobilize cells for bone tissue regeneration. The viability, metabolic activity, morphology, and osteogenic differentiation of immobilized MC3T3-E1 preosteoblats demonstrate the potential of this polysaccharide to keep immobilized cells viable and differentiating. Preosteoblasts immobilized in both types of pectin microspheres maintained a constant viability up to 29 days and were able to differentiate. The grafting of the RGD peptide on pectin backbone induced improved cell adhesion and proliferation within the microspheres. Furthermore, not only did cells grow inside but also theywere able to spread out from themicrospheres and to organize themselves in 3D structures producing a mineralized extracellular matrix. These promising results suggest that pectin can be proposed as an injectable cell vehicle for bone tissue regeneration. {\textcopyright} 2011 American Chemical Society.},
	keywords = {3-D Cell culture, 3D Structure, 3T3 Cells, Adhesion, Alginate, animal cell, Animals, arginylglycylaspartic acid, article, Biocompatible Materials, Biopolymers, Bone, Bone and Bones, Bone Regeneration, bone tissue, Bone tissue engineering, Bone tissue regeneration, carbohydrate analysis, cell adhesion, Cell culture, cell differentiation, cell growth, cell metabolism, cell proliferation, cell spreading, cell structure, cell viability, Cells, Chemical modification, Chemical structure, controlled study, Cryoelectron Microscopy, Extracellular matrices, extracellular matrix, gene expression, immobilized cell, Immobilized cells, Injectable biomaterials, Injections, MC3T3-E1, Metabolic activity, Mice, Microscopy, Electron, Scanning, microsphere, Microspheres, Mineralized extracellular matrixes, mouse, Natural polysaccharide, nonhuman, Oligopeptides, osteoblast, osteocalcin, Osteogenic differentiation, pectin, Pectins, Plant cell culture, Plant cell wall, Preosteoblasts, priority journal, RGD peptide, Three dimensional, Tissue engineering},
	isbn = {15257797 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79955409005\&partnerID=40\&md5=277a7d5e91116f9a03f144aabda0dd96},
	author = {Munarin, F. and Guerreiro, S.G. and Grellier, M.A. and Tanzi, M.C. and Barbosa, M.A. and Petrini, P. and Granja, P.L.}
}
@article {2248,
	title = {Influence of crystallite size of nanophased hydroxyapatite on fibronectin and osteonectin adsorption and on MC3T3-E1 osteoblast adhesion and morphology},
	journal = {Journal of Colloid and Interface ScienceJ. Colloid Interface Sci.},
	volume = {351},
	year = {2010},
	note = {Cited By (since 1996): 12Export Date: 21 November 2012Source: ScopusCODEN: JCISAdoi: 10.1016/j.jcis.2010.08.013PubMed ID: 20810127Language of Original Document: EnglishCorrespondence Address: Ribeiro, N.; INEB - Instituto de Engenharia Biom{\'e}dica, Divis{\~a}o de Biomateriais, Universidade do Porto, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: nribeiro@ineb.up.ptChemicals/CAS: fibronectin, 86088-83-7; hydroxyapatite, 1306-06-5, 51198-94-8; osteonectin, 104052-78-0; protein, 67254-75-5; Ceramics; Durapatite, 1306-06-5; Fibronectins; OsteonectinReferences: Griffith, L.G., Naughton, G., (2002) Science, 295, p. 1009;Webster, T.J., Ergun, C., Doremus, R.H., Siegel, R.W., Bizios, R., (2000) J. Biomed. Mater. Res., 51, pp. 475-483; 
Webster, T.J., Siegel, R.W., Bizios, R., (1999) Biomaterials, 20, pp. 1221-1227; 
Jun, I.K., Jang, J.H., Kim, H.W., Kim, H.E., (2005) J. Mater. Sci., 40, pp. 2891-2895; 
Geiger, B., Bershadsky, A., Pankov, R., Yamada, K.M., (2001) Nat. Rev. Mol. Cell Biol., 2, pp. 793-805; 
Globus, R.K., Doty, S.B., Lull, J.C., Holmuhamedov, E., Humphries, M.J., Damsky, C.H., (1998) J. Cell Sci., 111, pp. 1385-1393; 
Moursi, A.M., Damsky, C.H., Lull, J., Zimmerman, D., Doty, S.B., Aota, S.I., Globus, R.K., (1996) J. Cell Sci., 109, pp. 1369-1380; 
Garcia, A.J., Vega, M.D., Boettiger, D., (1999) Mol. Biol. Cell, 10, pp. 785-798; 
Petrie, T.A., Capadona, J.R., Reyes, C.D., Garcia, A.J., (2006) Biomaterials, 27, pp. 5459-5470; 
Dolatshahi-Pirouz, A., Jensen, T., Foss, M., Chevallier, J., Besenbacher, F., (2009) Langmuir, 25, pp. 2971-2978; 
Shen, J.-W., Wu, T., Wang, Q., Pan, H.-H., (2008) Biomaterials, 29, pp. 513-532; 
Brekken, R.A., Sage, E.H., (2000) Matrix Biol., 19, pp. 569-580; 
Termine, J.D., Kleinman, H.K., Whitson, S.W., Conn, K.M., McGarvey, M.L., Martin, G.R., (1981) Cell, 26, pp. 99-105; 
Liao, S., Ngiam, M., Chan, C.K., Ramakrishna, S., (2009) Biomed. Mater., 4; 
Sarvestani, A.S., He, X., Jabbari, E., (2008) Eur. Biophys. J. Biophys. Lett., 37, pp. 229-234; 
Majeska, R.J., Cell Biology of Bone (1934), pp. 2-3. , in: S.C. Cowin (Ed.), Bone Mechanics HandbookKoblinski, J.E., Wu, M., Demeler, B., Jacob, K., Kleinman, H.K., (2005) J. Cell Sci., 118, pp. 2965-2974; 
O{\textquoteright}Brien, J., Wilson, I., Orton, T., Pognan, F., (2000) Eur. J. Biochem., 267, pp. 5421-5426; 
Ribeiro, C.C., Gibson, I., Barbosa, M.A., (2006) Biomaterials, 27, pp. 1749-1761; 
Lopes, M.A., Monteiro, F.J., Santos, J.D., Serro, A.P., Saramago, B., (1999) J. Biomed. Mater. Res., 45, pp. 370-375; 
Suzuki, T., Nishizawa, K., Yokogawa, Y., Nagata, F., Kawamoto, Y., Kameyama, T., (1996) J. Ferment. Bioeng., 81, pp. 226-232; 
Suzuki, T., Yamamoto, T., Toriyama, M., Nishizawa, K., Yokogawa, Y., Mucalo, M.R., Kawamoto, Y., Kameyama, T., (1997) J. Biomed. Mater. Res., 34, pp. 507-517; 
Holland, N.B., Marchant, R.E., (2000) J. Biomed. Mater. Res., 51, pp. 307-315; 
Kothapalli, C., Wei, M., Vasiliev, A., Shaw, M.T., (2004) Acta Mater., 52, pp. 5655-5663; 
Sousa, S.R., Manuela Bras, M., Moradas-Ferreira, P., Barbosa, M.A., (2007) Langmuir, 23, pp. 7046-7054; 
Rouahi, M., Champion, E., Gallet, O., Jada, A., Anselme, K., (2006) Colloids Surf., B - Biointerfaces, 47, pp. 10-19; 
dos Santos, E.A., Farina, M., Soares, G.A., Anselme, K., (2008) J. Mater. Sci. - Mater. Med., 19, pp. 2307-2316; 
Amaral, I.F., Unger, R.E., Fuchs, S., Mendonca, A.M., Sousa, S.R., Barbosa, M.A., Pego, A.P., Kirkpatrick, C.J., (2009) Biomaterials, 30, pp. 5465-5475; 
Sousa, S.R., Moradas-Ferreira, P., Barbosa, M.A., (2005), pp. 1173-1178. , TiO2 type influences fibronectin adsorption, in: 19th Conference of the European-Society-for-Biomaterials, Springer, Sorrento, ItalyGoldstein, A.S., DiMilla, P.A., (2002) J. Biomed. Mater. Res., 59, pp. 665-675; 
Michael, K.E., Vernekar, V.N., Keselowsky, B.G., Meredith, J.C., Latour, R.A., Garcia, A.J., (2003) Langmuir, 19, pp. 8033-8040; 
Anselme, K., Bigerelle, M., (2005) Acta Biomater., 1, pp. 211-222; 
Anselme, K., Bigerelle, M., Noel, B., Dufresne, E., Judas, D., Iost, A., Hardouin, P., (2000) J. Biomed. Mater. Res., 49, pp. 155-166; 
Wang, C., Duan, Y., Markovic, B., Barbara, J., Rolfe Howlett, C., Zhang, X., Zreiqat, H., (2004) Biomaterials, 25, pp. 2949-2956; 
Smith, I.O., McCabe, L.R., Baumann, M.J., (2006) Int. J. Nanomed., 1, pp. 189-194; 
Bernards, M.T., Qin, C.L., Jiang, S.Y., Bone osteopontin, and bovine serum albumin (2008) Colloids Surf., B - Biointerfaces, 64, pp. 236-247; 
Durrieu, M.C., Pallu, S., Guillemot, F., Bareille, R., Amedee, J., Baquey, C., Labrugere, C., Dard, M., (2004) J. Mater. Sci. - Mater. Med., 15, pp. 779-786; 
Itoh, D., Yoneda, S., Kuroda, S., Kondo, H., Umezawa, A., Ohya, K., Ohyama, T., Kasugai, S., (2002) J. Biomed. Mater. Res., 62, pp. 292-298; 
Funk, S.E., Sage, E.H., (1993) J. Cell. Physiol., 154, pp. 53-63; 
Hagan, S., Hiscott, P., Sheridan, C., Wong, D., Grierson, I., McGalliard, J., (2003) Mol. Vis., 9, pp. 87-92; 
Deligianni, D., Korovessis, P., Porte-Derrieu, M.C., Amedee, J., (2005) J. Spinal Disord. Technol., 18, pp. 257-262; 
Nelson, M., Balasundaram, G., Webster, T.J., (2006) Int. J. Nanomed., 1, pp. 339-349
},
	month = {2010///},
	pages = {398 - 406},
	abstract = {The characteristic topographical features (crystallite dimensions, surface morphology and roughness) of bioceramics may influence the adsorption of proteins relevant to bone regeneration. This work aims at analyzing the influence of two distinct nanophased hydroxyapatite (HA) ceramics, HA725 and HA1000 on fibronectin (FN) and osteonectin (ON) adsorption and MC3T3-E1 osteoblast adhesion and morphology. Both substrates were obtained using the same hydroxyapatite nanocrystals aggregates and applying the sintering temperatures of 725{\textdegree}C and 1000{\textdegree}C, respectively. The two proteins used in this work, FN as an adhesive glycoprotein and ON as a counter-adhesive protein, are known to be involved in the early stages of osteogenesis (cell adhesion, mobility and proliferation). The properties of the nanoHA substrates had an important role in the adsorption behavior of the two studied proteins and clearly affected the MC3T3-E1 morphology, distribution and metabolic activity. HA1000 surfaces presenting slightly larger grain size, higher root-mean-square roughness (Rq), lower surface area and porosity, allowed for higher amounts of both proteins adsorbed. These substrates also revealed increased number of exposed FN cell-binding domains as well as higher affinity for osteonectin. Regarding the osteoblast adhesion results, improved viability and cell number were found for HA1000 surfaces as compared to HA725 ones, independently of the presence or type of adsorbed protein. Therefore the osteoblast adhesion and metabolic activity seemed to be more sensitive to surfaces morphology and roughness than to the type of adsorbed proteins. {\textcopyright} 2010 Elsevier Inc.},
	keywords = {Adhesion, Adhesive proteins, Adsorption, Adsorption behavior, Animals, Apatite, article, Bioceramics, Biological materials, Biomaterials, bone development, Bone Regeneration, cell adhesion, Cell Count, cell metabolism, cell motility, Cell number, cell proliferation, cell strain 3T3, cell structure, Cell-binding domain, Cells, Cultured, cellular distribution, ceramics, controlled study, Crystallite dimension, Crystallite size, Crystallization, Durapatite, Fibronectin, Fibronectin adsorption, Fibronectins, glycoprotein, grain, Grain size, human, human cell, hydroxyapatite, Hydroxyapatite nanocrystals, MC3T3-E1, Metabolic activity, metabolism, Mice, morphology, Nano-HA, nanocrystal, nanoparticles, Nanophased hydroxyapatite, osteoblast, Osteoblast adhesion, Osteoblast morphology, Osteoblasts, Osteogenesis, osteonectin, Osteonectin adsorption, Particle Size, porosity, priority journal, protein, Proteins, Root mean square roughness, Sintering, Sintering temperatures, Surface area, Surface Properties, surface property, Surface roughness, temperature, Topographical features},
	isbn = {00219797 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-77957328472\&partnerID=40\&md5=c4a13ccec89e04dbfe1920fd42fec3f5},
	author = {Ribeiro, N. and Sousa, S.R. and Monteiro, F.J.}
}
@article {2408,
	title = {Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts},
	journal = {Journal of Cellular BiochemistryJ. Cell. Biochem.},
	volume = {98},
	year = {2006},
	note = {Cited By (since 1996): 17Export Date: 21 November 2012Source: ScopusCODEN: JCEBDdoi: 10.1002/jcb.20853PubMed ID: 16479591Language of Original Document: EnglishCorrespondence Address: Lamghari, M.; INEB-Instituto de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua Campo Alegre 823, 4150-180, Porto, Portugal; email: lamghari@ineb.up.ptChemicals/CAS: osteoclast differentiation factor, 200145-93-3; osteoprotegerin, 205944-50-9; Alkaline Phosphatase, EC 3.1.3.1; Carrier Proteins; Glycoproteins; leptin receptor; Leptin; Membrane Glycoproteins; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; RNA, Messenger; Tnfrsf11a protein, mouse; Tnfrsf11b protein, mouse; Tnfsf11 protein, mouseReferences: Burguera, B., Hofbauer, L.C., Thomas, T., Gori, F., Evans, G.L., Khosla, S., Riggs, B.L., Turner, R.T., Leptin reduces ovariectomy-induced bone loss in rats (2001) Endocrinology, 142, pp. 3546-3553;Cornish, J., Callon, K.E., Bava, U., Lin, C., Naot, D., Hill, B.L., Grey, A.B., Reid, I.R., Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo (2002) J Endocrinol, 175, pp. 405-415; 
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Karsenty, G., Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass (2000) Cell, 100, pp. 197-207; 
Elefteriou, F., Ahn, J.D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Karsenty, G., Leptin regulation of bone resorption by the sympathetic nervous system and CART (2005) Nature, 434, pp. 514-520; 
Elmquist, J.K., Hypothalamic pathways underlying the endocrine, autonomic, and behavioral effects of leptin (2001) Physiol Behav, 74, pp. 703-708; 
Gordeladze, J.O., Drevon, C.A., Syversen, U., Reseland, J.E., Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling (2002) J Cell Biochem, 85, pp. 825-836; 
Holloway, W.R., Collier, F.M., Aitken, C.J., Myers, D.E., Hodge, J.M., Malakellis, M., Gough, T.J., Nicholson, G.C., Leptin inhibits osteoclast generation (2002) J Bone Miner Res, 17, pp. 200-209; 
Horwood, N.J., Elliott, J., Martin, T.J., Gillespie, M.T., Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells (1998) Endocrinology, 139, pp. 4743-4746; 
Kanematsu, M., Yoshimura, K., Takaoki, M., Sato, A., Vector-averaged gravity regulates gene expression of receptor activator of NF-κB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway (2002) Bone, 30, pp. 553-558; 
Lacely, D.L., Timms, E., Tan, H.L., Dunstan, C.R., Burgess, T., Elliott, R., Colombero, A., Boyle, W.J., Osteoproteferin ligand is a cytokine that regulates osteoclast differentiation and activation (1998) Cell, 93, pp. 165-167; 
Lee, S.K., Lorenzo, J.A., Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation (1999) Endocrinology, 140, pp. 3552-3561; 
Lee, S.K., Lorenzo, J.A., Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures (2002) Bone, 31, pp. 252-259; 
Lee, Y.J., Park, J.H., Ju, S.K., You, K.H., Ko, J.S., Kim, H.M., Leptin receptor isoform expression in rat osteoblasts and their functional analysis (2002) FEBS Lett, 528, pp. 43-47; 
Liu, J., Yang, H., Liu, W., Cao, X., Feng, X., Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells (2005) J Cell Biochem, 96 (4), pp. 716-727; 
Martin, A., De Vittoris, R., David, V., Moraes, R., B{\'e}geot, M., Lafage-Proust, M.H., Alexandre, C., Thomas, T., Leptin modulates both r{\'e}sorption and formation while preventing disuse-induced bone loss in tail-suspended female rats (2005) Endocrinology, 146, pp. 3652-3659; 
Nagai, M., Sato, N., Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation (1999) Biochem Biophys Res Commun, 257, pp. 719-723; 
Nakajima, R., Inada, H., Koike, T., Yamano, T., Effects of leptin to cultured growth plate chondrocytes (2003) Horm Res, 60 (2), pp. 91-98; 
Parhami, F., Tintut, Y., Ballard, A., Fogelman, A.M., Demer, L.L., Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin (2001) Circ Res, 88 (9), pp. 954-960; 
Reseland, J.E., Syversen, U., Bakke, I., Ovigstad, G., Eide, L.G., Hjertner, O., Gordeladze, J.O., Drevon, C.A., Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization (2001) J Bone Miner Res, 16, pp. 1426-11414; 
Rubin, J., Ackert-Bicknell, C., Zhu, L., Fan, X., Murphy, T., Nanes, M., Marcus, R., Rosen, C., Insulin like growth factor-I (IGF-I) regulates osteoprotegerin (OPG) and RANK ligand (RANKL) in vitro and osteoprotogerin in vivo (2002) J Clin Endocrinal Metab, 87, pp. 4273-4279; 
Rubin, J., Murphy, T., Fan, X., Goldschmidt, M., Taylor, W., Mechanical strain inhibits RANKL expression through activation of ERK1/2 in bone marrow stromal cells (2002) J Bone Miner Res, 17, pp. 1452-1460; 
Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Boyle, W.J., Osteoprotegerin: A novel secreted protein involved in the regulation of bone density (1997) Cell, 89, pp. 309-319; 
Steppan, C.M., Crawford, T., Chidsey-Frink, K.L., Ke, H.Z., Swick, A.G., Leptin is a potent stimulator of bone growth in ob/ob mice (2000) Regul Pept, 92, pp. 73-78; 
Suda, T., Ueno, Y., Fujii, K., Shinki, T., Vitamin D and bone (2003) J Cell Biochem, 88, pp. 259-266; 
Thomas, T., Gori, F., Khosla, S., Jensen, M.D., Burguera, B., Riggs, B.L., Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes (1999) Endocrinology, 140, pp. 1630-1638; 
Udagawa, N., Takahashi, N., Yasuda, H., Mizuno, A., Itoh, K., Ueno, Y., Shinki, T., Suda, T., Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function (2000) Endocrinology, 141, pp. 3478-3484; 
Wamoto, I., Fujino, T., Douchi, T., The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism (2004) Gynecol Endocrinol, 19, pp. 97-104; 
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Suda, T., Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL (1998) Proc Natl Acad Sci USA, 95, pp. 3597-3602
},
	month = {2006///},
	pages = {1123 - 1129},
	abstract = {Recent studies have suggested that leptin hormone may play a pivotal role on bone remodeling through a direct effect by modulating positively the OPG/RANKL balance. Here, we investigate the effect of leptin hormone on RANKL and OPG expression in MC3T3-E1 osteoblasts using RT-PCR and ELISA measurements. We have at first identified the expression of Ob-Rb and Ob-Ra leptin receptor isoforms in MC3T3-E1 and observed that these cells respond to mrleptin treatments. We then investigated the effect of mrleptin on RANKL and OPG expression. We show that mrleptin dose-dependently regulated the expression of RANKL mRNA with complete inhibition observed at concentrations higher than 12 ng/ml. This effect was confirmed with sRANKL protein measurements. However, the exposure of MC3T3-E1 to mrleptin had no effect on OPG mRNA. Taken together, these results suggest that leptin modulates positively OPG/RANKL balance by inhibiting the expression of RANKL gene. {\textcopyright} 2006 Wiley-Liss, Inc.},
	keywords = {alkaline phosphatase, animal cell, Animals, article, bone remodeling, Carrier Proteins, Cell Line, enzyme linked immunosorbent assay, gene expression, gene expression regulation, Glycoproteins, hormone action, leptin, leptin receptor, leptin receptor a, leptin receptor b, MC3T3-E1, Membrane Glycoproteins, messenger RNA, Mice, mouse, nonhuman, Ob-Ra, Ob-Rb, OPG, osteoblast, Osteoblasts, osteoclast differentiation factor, Osteoprotegerin, priority journal, protein expression, RANK Ligand, RANKL, Receptor Activator of Nuclear Factor-kappa B, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear, Receptors, Tumor Necrosis Factor, reverse transcription polymerase chain reaction, RNA extraction, RNA, Messenger, unclassified drug},
	isbn = {07302312 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-33746452603\&partnerID=40\&md5=f5eb37e7159ced26f3b7e756d59bc1bb},
	author = {Lamghari, M. and Tavares, L. and Camboa, N. and Barbosa, M.A.}
}
